Cul-mediated cross-coupling of aryl halides with oximes: A direct access to O-aryloximes

Organic Letters

Volumn 9, Issue 15, 2007, Pages 2767-2770

  De Prithwiraj, ^c   Nonappa, ^c   Pandurangan, Komala ^c   Maitra, Uday ^a   Wailes, Steve ^b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; HALOGEN; IODIDE; OXIME;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY;

COPPER; HALOGENS; IODIDES; MODELS, MOLECULAR; OXIMES;

EID: 34547192158     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0709578     Document Type: Article

References (23)

1. (a) Mailliet, P.; Ruxer, J. M.; Thompson, F.; Luc, C. C. New 3-aryl1,2-benzisoxazole derivatives, compositions containing them and their use for treating cancer. French Patent FR 288236, August 25, 2006.
2. (b) Yoshimi, K.; Kozuka, M.; Sakai, J.; Lizawa, T.; Shimizu, Y.; Kaniko, I.; Kojima, K.; Iwata, N. Jpn. J. Pharmacol. 2002, 88, 174.
3. (c) Ricci, A.; Carra, A.; Torelli, A.; Maggiali, C. A.; Vicini, P.; Zani, F.; Branca, C. Plant Growth Regul. 2001, 34, 167.
4. (d) Strupczewski, J. T.; Allen, R. C.; Gardner, B. A.; Schmid, B. L.; Stache, U.; Glamkowski, E. J.; Jones, M. C.; Ellis, D. B.; Huger, F. P.; Dunn. R. W. J. Med. Chem. 1985, 28, 761.
5. (a) Chakrapani, H.; Toone, E. J. Abstracts of Papers. 230th ACS National Meeting; Washington, DC, Aug 28-Sept 1, 2005; American Chemical Society: Washington, DC, 2005; MED-414.
6. (b) Yu, Q-s; Zhu, X.; Holloway, H. W.; Whittaker, N. F.; Brossi, A.; Greig, N. H. J. Med. Chem. 2002, 45, 3684.
7. (c) Clark, B. P.; Harris, J.; Richard; K.; Ann, E. Preparation of 6-aryl-3,6-dihydro-1,2-oxazines as mGluRl receptor antagonists. UK Patent WO 2000026199, May 11, 2000.
8. (a) Johnson, S. M.; Petrassi, H. M.; Palaninathan, S. K.; Mohamed-mohaideen, N. N.; Purkey, H. E.; Nichols, C.; Chiang, K. P.; Walkup, T.; Sacchettini, J. C.; Sharpless, K. B. and Kelly, J. W. J. Med. Chem. 2005, 48, 1576.
9. (b) Blake, J. A.; Pratt, D. A; Lin, S.; Walton, J. C.; Mulder, P.; Ingold, K. U. J. Org. Chem. 2004, 69, 3112.
10. (a) Mooradian, A.; Dupont, P. E. J. Heterocycl. Chem. 1967, 4, 441.
11. (b) Jacob, B. B. Synthesis 1975, 782.
12. (c) Nesynov, E. P. Zh. Org. Khim. 1976, 12, 1955.
13. 2.
14. Carril, M.; SanMartin, R.; Tellitu, I.; Dominguez, E. Org. Lett. 2006, 8, 1467.
15. (a) Wolter, M.; Nordmann, G.; Job, G. E.; Buchwald, S. L. Org. Lett. 2002, 4, 973.
16. (b) Kunz, K.; Scholz, U.; Gazner, D. Synlett 2003, 2428.
17. When water was chosen as solvent, 1 produced la in comparable yields (80%) and the aqueous extract showed a blue color, indicating the formation of Cu(II).
18. (a) Kaminskaia, N. V.; Kostić, N. M. J. Chem. Soc., Dalton Trans. 2001, 1083.
19. (b) Attanasi, O.; Gasperoni, S.; Carletti, C.; J. Prakt. Chem. 1980, 1063.
20. (c) Onindo, C. O.; Sliva, Y, T.; Jankowska, T. K.; Fritsky, I. O.; Buglyo, P.; Pettit, L. D.; Kozlowski, H.; Kiss, T. J. Chem. Soc, Dalton Trans. 1995, 3911.
21. (a) Sing, E. J.; Dey, A. K. Z. Analyt. Chem. 1959, 165, 81.
22. (b) Baffi, F.; Dadone, A.; Frache, R. Chromatographia 1976, 9, 280. These references clearly suggest that Cu(II) forms a stable complex above 2.0 equiv of tartrate.
23. A control experiment was carried out by flushing the reaction vessel with oxygen. The reaction was then carried out with the standard reaction conditions under oxygen atmosphere, resulting in deoximation (up to 80%). No oxime ether formation was observed.